Cargando…

3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma

PURPOSE: Circulating tumor cells (CTCs) are considered to be a key factor involved in tumor metastasis. However, the isolation and culture of CTCs in vitro remains challenging, and their clinical application for predicting prognosis and survival is still limited. The development of accurate evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Cong-Li, Zhang, Yan-Jun, Zhang, Xiao-Feng, Fei, Xiang, Zhang, Hai, Li, Chun-Guang, Sun, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057830/ https://www.ncbi.nlm.nih.gov/pubmed/33888992 http://dx.doi.org/10.2147/OTT.S298427

Ejemplares similares

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
por: Zhu, Gui‐Qi, et al.
Publicado: (2021)

Isolated metastasis of hepatocellular carcinoma in the right ventricle
por: Zhang, Xin-tong, et al.
Publicado: (2019)

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells
por: Liu, Chang, et al.
Publicado: (2016)

Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses
por: Yin, Liang-Chun, et al.
Publicado: (2018)

Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma
por: Yu, Jing, et al.
Publicado: (2021)

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
por: Chen, Jing, et al.
Publicado: (2022)

Risk Factors for Brain Metastasis of Hepatocellular Carcinoma
por: Wang, Lei, et al.
Publicado: (2022)

Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells
por: Sun, Bin, et al.
Publicado: (2017)

A splicing variant of Merlin promotes metastasis in hepatocellular carcinoma
por: Luo, Zai-Li, et al.
Publicado: (2015)

SEPT2 crotonylation promotes metastasis and recurrence in hepatocellular carcinoma and is associated with poor survival
por: Zhang, Xin-yue, et al.
Publicado: (2023)

Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection
por: Zhou, Yan-Ming, et al.
Publicado: (2015)

Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging
por: Li, Qian, et al.
Publicado: (2023)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation
por: NG, Kevin Tak-Pan, et al.
Publicado: (2016)

Failure recovery of circulating NKG2D(+)CD56(dim)NK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence
por: Gao, Jian, et al.
Publicado: (2015)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy
por: Lu, Zhan, et al.
Publicado: (2023)

High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells
por: Lu, Zhan, et al.
Publicado: (2023)

Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection
por: Huang, Xinhui, et al.
Publicado: (2014)

Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models
por: You, Abin, et al.
Publicado: (2016)

A Critical Role for ZDHHC2 in Metastasis and Recurrence in Human Hepatocellular Carcinoma
por: Peng, Chuanhui, et al.
Publicado: (2014)

Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery
por: Gao, Rui-Qian, et al.
Publicado: (2023)

Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma
por: Chen, Yunyang, et al.
Publicado: (2019)

Emerging role of long noncoding RNAs in recurrent hepatocellular carcinoma
por: Fang, Yuan, et al.
Publicado: (2021)

Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood
por: Wang, Zhong, et al.
Publicado: (2017)

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma
por: Wang, Jian, et al.
Publicado: (2020)

Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma
por: Li, Tao, et al.
Publicado: (2016)

Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma
por: Tang, Junwei, et al.
Publicado: (2015)

MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2018)

The Predictive Value of CA-125 and Hb for Ocular Metastasis in Hepatocellular Carcinoma Patients
por: Xiong, Xin, et al.
Publicado: (2022)

Predictors of early and late hepatocellular carcinoma recurrence
por: Nevola, Riccardo, et al.
Publicado: (2023)

B7-H4 overexpression is essential for early hepatocellular carcinoma progression and recurrence
por: Kang, Fu-Biao, et al.
Publicado: (2017)

Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
por: Xu, Wei, et al.
Publicado: (2020)

Smaller grafts do not imply early recurrence in recipients transplanted for hepatocellular carcinoma: A Chinese experience
por: Hu, Zhenhua, et al.
Publicado: (2016)

Plasmodium infection prevents recurrence and metastasis of hepatocellular carcinoma possibly via inhibition of the epithelial-mesenchymal transition
por: Liang, Yun, et al.
Publicado: (2021)

Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction
por: Zhang, Zhen, et al.
Publicado: (2019)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Fan, Wenzhe, et al.
Publicado: (2015)

Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
por: Niu, Zhao-Shan, et al.
Publicado: (2022)

XB130 Knockdown Inhibits the Proliferation, Invasiveness, and Metastasis of Hepatocellular Carcinoma Cells and Sensitizes them to TRAIL-Induced Apoptosis
por: Li, Guang-Ming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7df0uc8cdkbchipmv451p7vb3s